Back
Monte Rosa Therapeutics Vs. DocuSign Industry Stock Comparison
Buy
64
GLUE
Monte Rosa Therapeutics
Last Price:
$6.29
Seasonality Move:
-24.75%
Buy
82
DOCU
DocuSign
Last Price:
$85.72
Seasonality Move:
15.31%
Buy
64
Monte Rosa Therapeutics (GLUE)
is a Buy
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
-
The current Monte Rosa Therapeutics [GLUE] share price is $6.27. The Score for GLUE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
GLUE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $6.27The current trend is relatively stagnant and GLUE is experiencing slight selling pressure.
DOCU Stock Price Chart
GLUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 51.1 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.85 - 6.69) | Sell |
Bollinger Bands (100): | (5.7 - 8.62) | Sell |
DOCU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.64 | Sell |
Relative Strength Index (14 RSI): | 53.41 | Buy |
Chaikin Money Flow: | 3107309 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (79.97 - 89.85) | Buy |
Bollinger Bands (100): | (76.52 - 94.14) | Buy |
GLUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.23 | Buy |
20-day SMA: | 6.19 | Buy |
50-day SMA: | 6.24 | Buy |
200-day SMA: | 5.96 | Buy |
8-day EMA: | 6.22 | Buy |
20-day EMA: | 6.2 | Buy |
50-day EMA: | 6.42 | Sell |
200-day EMA: | 6.33 | Sell |
DOCU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 80.51 | Buy |
20-day SMA: | 83.13 | Buy |
50-day SMA: | 88.51 | Sell |
200-day SMA: | 70.82 | Buy |
8-day EMA: | 80.97 | Buy |
20-day EMA: | 83.26 | Buy |
50-day EMA: | 85.79 | Sell |
200-day EMA: | 75.3 | Buy |
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.24 per share.
DocuSign Earnings Growth & DOCU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.00 per share, an increase this year of $0.66 per share, and a decrease next year of $0.04 per share.
Monte Rosa Therapeutics Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
DocuSign Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |